YasarTorres-YaghiMD

Neurology • Washington, DC

Movement Disorder, Dementia & Geriatrics

Director of the Parkinsonism and Dementia Clinic

Join to view full profile

Dr. Torres-Yaghi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Torres-Yaghi's full profile

Already have an account?

Office
3800 Reservoir Rd Nw
Department Of Neurology
Washington, DC 20007
Phone+1 202-444-2000

Education & Training

MedStar Health/Georgetown University HospitalResidency, Neurology, 2012 - 2015
MedStar Health (Baltimore)Internship, Internal Medicine, 2011 - 2012
George Washington University School of Medicine and Health SciencesClass of 2011

Certifications & Licensure

VA State Medical License 2012 - 2026
DC State Medical License 2015 - 2024
MD State Medical License 2015 - 2023
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

25 citations
Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases
Alan J. Fowler, Michaeline Hebron, Kaluvu Balaraman, Wangke Shi, Alexander A Missner
Human Molecular Genetics. 2020-10-10
36 citations
Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
Fernando Pagan, Barbara Wilmarth, Yasar Torres-Yaghi, Michaeline Hebron, Sanjana Mulki
Movement Disorders. 2021-03-01
111 citations
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.
Fernando Pagan, Michaeline Hebron, Barbara Wilmarth, Yasar Torres-Yaghi, Abigail Lawler
JAMA Neurology. 2020-03-01

Press Mentions

Kyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (Istradefylline) and Other Parkinson's Disease Add-on TherapiesApril 13th, 2024